Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.

Yu-Chou Tseng, Samuel K Kulp, I-Lu Lai, En-Chi Hsu and 6 more